{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:41:09Z","timestamp":1772822469037,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":4507,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2002]]},"DOI":"10.1038\/sj.neo.7900245","type":"journal-article","created":{"date-parts":[[2002,9,3]],"date-time":"2002-09-03T21:14:45Z","timestamp":1031087685000},"page":"312-323","source":"Crossref","is-referenced-by-count":54,"title":["Antitumor Activity and Prolonged Expression from a TRAIL-Expressing Adenoviral Vector"],"prefix":"10.1016","volume":"4","author":[{"given":"Jeongwu","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Hampl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Albert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard A.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/sj.neo.7900245_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0092-8674(94)90518-5","article-title":"Apoptosis in cancer therapy: crossing the threshold","volume":"78","author":"Fisher","year":"1994","journal-title":"Cell"},{"key":"10.1038\/sj.neo.7900245_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"10.1038\/sj.neo.7900245_bib3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.277.5327.768","article-title":"How TRAIL kills cancer cells, but not normal cells","volume":"277","author":"Gura","year":"1997","journal-title":"Science"},{"key":"10.1038\/sj.neo.7900245_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.neo.7900245_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"10.1038\/sj.neo.7900245_bib6","first-page":"1162","article-title":"Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells","volume":"61","author":"Hao","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/sj.neo.7900245_bib7","first-page":"3330","article-title":"Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene","volume":"61","author":"Kagawa","year":"2001","journal-title":"Cancer Res"},{"key":"10.1038\/sj.neo.7900245_bib8","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/75045","article-title":"Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand","volume":"6","author":"Jo","year":"2000","journal-title":"Nat Med"},{"key":"10.1038\/sj.neo.7900245_bib9","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(00)02659-3","article-title":"Human brain-cell death induced by tumournecrosis factor inducing ligand (TRAIL)","volume":"356","author":"Nitsch","year":"2000","journal-title":"Lancet"},{"key":"10.1038\/sj.neo.7900245_bib10","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86397","article-title":"Differential hepatocyte toxicity of recombinant Apo2L\/TRAIL versions","volume":"7","author":"Lawrence","year":"2001","journal-title":"Nat Med"},{"key":"10.1038\/sj.neo.7900245_bib11","first-page":"1362","article-title":"Direct stimulation of apoptotic signaling by soluble apo2l\/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells","volume":"7","author":"Pollack","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1038\/sj.neo.7900245_bib12","first-page":"3362","article-title":"Viral vectortargeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA","volume":"58","author":"Tanaka","year":"1998","journal-title":"Cancer Res"},{"key":"10.1038\/sj.neo.7900245_bib13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nm0497-437","article-title":"Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth","volume":"3","author":"Tanaka","year":"1997","journal-title":"Nat Med"},{"key":"10.1038\/sj.neo.7900245_bib14","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.neo.7900245_bib15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/13550289809114519","article-title":"Immune parameters affecting adenoviral vector gene therapy in the brain","volume":"4","author":"Parr","year":"1998","journal-title":"J Neurovirol"},{"key":"10.1038\/sj.neo.7900245_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0014-5793(98)00409-8","article-title":"AP02 ligand: a novel lethal weapon against malignant glioma?","volume":"427","author":"Rieger","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1038\/sj.neo.7900245_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1006\/exnr.1999.7098","article-title":"In vitro expansion of a multipotent population of human neural progenitor cells","volume":"158","author":"Carpenter","year":"1999","journal-title":"Exp Neurol"},{"key":"10.1038\/sj.neo.7900245_bib18","first-page":"734","article-title":"Chemotherapy augments TRAIL-induced apoptosis in breast cell lines","volume":"59","author":"Keane","year":"1999","journal-title":"Cancer Res"},{"key":"10.1038\/sj.neo.7900245_bib19","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/15207","article-title":"Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovrus-mediated gene therapy: implications for clinical trials","volume":"5","author":"Dewey","year":"1999","journal-title":"Nat Med"},{"key":"10.1038\/sj.neo.7900245_bib20","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1126\/science.270.5239.1189","article-title":"Fas ligand-induced apoptosis as a mechanism of immune privilege","volume":"270","author":"Griffith","year":"1995","journal-title":"Science"},{"key":"10.1038\/sj.neo.7900245_bib21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/377630a0","article-title":"A role for CD95 ligand in preventing graft rejection","volume":"377","author":"Bellgrau","year":"1995","journal-title":"Nature"},{"key":"10.1038\/sj.neo.7900245_bib22","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.277.5327.815","article-title":"An antagonist decoy receptor and a death domain-containing receptor for TRAIL","volume":"277","author":"Pan","year":"1997","journal-title":"Science"},{"key":"10.1038\/sj.neo.7900245_bib23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.277.5327.818","article-title":"Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors","volume":"277","author":"Sheridan","year":"1997","journal-title":"Science"},{"key":"10.1038\/sj.neo.7900245_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0955-0674(99)80034-9","article-title":"Apoptosis control by death and decoy receptors","volume":"11","author":"Ashkenazi","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"10.1038\/sj.neo.7900245_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02592977","article-title":"Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily","volume":"26","author":"Gruss","year":"1996","journal-title":"Int J Clin Lab Res"},{"key":"10.1038\/sj.neo.7900245_bib26","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1074\/jbc.271.22.12687","article-title":"Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family","volume":"271","author":"Pitti","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.neo.7900245_bib27","first-page":"3051","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand retains its apopto-sis-inducing capacity on Bcl-2-or Bcl-xL-overexpressing chemotherapy-resistant tumor cells","volume":"60","author":"Walczak","year":"2000","journal-title":"Cancer Res"},{"key":"10.1038\/sj.neo.7900245_bib28","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1073\/pnas.030545097","article-title":"Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy","volume":"97","author":"Chinnaiyan","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.neo.7900245_bib29","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","article-title":"Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy","volume":"91","author":"Yang","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.neo.7900245_bib30","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.4049\/jimmunol.155.5.2564","article-title":"Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo","volume":"155","author":"Yang","year":"1995","journal-title":"J Immunol"},{"key":"10.1038\/sj.neo.7900245_bib31","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.4049\/jimmunol.163.9.4886","article-title":"\"Stealth effect\": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions","volume":"163","author":"Giovarelli","year":"1999","journal-title":"J Immunol"},{"key":"10.1038\/sj.neo.7900245_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.genet.33.1.29","article-title":"Fas ligand-induced apoptosis","volume":"33","author":"Nagata","year":"1999","journal-title":"Annu Rev Genet"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558602800264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558602800264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T23:03:48Z","timestamp":1682291028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558602800264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002]]}},"alternative-id":["S1476558602800264"],"URL":"https:\/\/doi.org\/10.1038\/sj.neo.7900245","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2002]]}}}